CVS Health Corp (CVS) Shares Bought by Poehling Capital Management LLC

Share on StockTwits

Poehling Capital Management LLC grew its position in CVS Health Corp (NYSE:CVS) by 27.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,446 shares of the pharmacy operator’s stock after acquiring an additional 7,380 shares during the period. CVS Health accounts for 1.9% of Poehling Capital Management LLC’s portfolio, making the stock its 12th largest holding. Poehling Capital Management LLC’s holdings in CVS Health were worth $2,712,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CVS. BlackRock Inc. increased its holdings in shares of CVS Health by 2.8% in the third quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after purchasing an additional 2,061,915 shares in the last quarter. FMR LLC increased its holdings in shares of CVS Health by 4.3% in the third quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after purchasing an additional 1,250,473 shares in the last quarter. Parnassus Investments CA increased its holdings in shares of CVS Health by 2.2% in the second quarter. Parnassus Investments CA now owns 16,659,501 shares of the pharmacy operator’s stock valued at $1,072,039,000 after purchasing an additional 350,872 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of CVS Health by 15.9% in the second quarter. Bank of New York Mellon Corp now owns 12,573,338 shares of the pharmacy operator’s stock valued at $809,095,000 after purchasing an additional 1,721,683 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of CVS Health by 0.6% in the second quarter. Dimensional Fund Advisors LP now owns 10,840,057 shares of the pharmacy operator’s stock valued at $697,653,000 after purchasing an additional 64,223 shares in the last quarter. Institutional investors own 84.50% of the company’s stock.

In other CVS Health news, CFO David M. Denton sold 25,159 shares of CVS Health stock in a transaction on Thursday, November 29th. The shares were sold at an average price of $80.13, for a total transaction of $2,015,990.67. Following the completion of the sale, the chief financial officer now owns 403 shares of the company’s stock, valued at approximately $32,292.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Troyen A. Brennan sold 14,229 shares of the business’s stock in a transaction on Wednesday, November 14th. The shares were sold at an average price of $82.00, for a total transaction of $1,166,778.00. The disclosure for this sale can be found here. Insiders have sold a total of 74,233 shares of company stock valued at $5,932,565 in the last ninety days. Company insiders own 0.53% of the company’s stock.

A number of brokerages recently weighed in on CVS. Leerink Swann raised their price target on shares of CVS Health from $85.00 to $95.00 and gave the company a “positive” rating in a report on Thursday, November 8th. Morgan Stanley set a $100.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Wednesday, November 7th. Wolfe Research began coverage on shares of CVS Health in a report on Thursday, October 25th. They issued a “peer perform” rating for the company. Goldman Sachs Group reissued a “neutral” rating and issued a $87.00 price target on shares of CVS Health in a report on Thursday, November 29th. Finally, Royal Bank of Canada set a $99.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $90.69.

CVS opened at $74.09 on Friday. The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $83.88. The firm has a market cap of $78.01 billion, a price-to-earnings ratio of 11.23, a price-to-earnings-growth ratio of 1.10 and a beta of 0.98.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion. During the same quarter in the previous year, the business earned $1.50 EPS. The business’s quarterly revenue was up 2.4% compared to the same quarter last year. Equities analysts expect that CVS Health Corp will post 7.03 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This story was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://baseballnewssource.com/2018/12/08/cvs-health-corp-cvs-shares-bought-by-poehling-capital-management-llc/3064763.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.